Systemic Lupus Erythematosus Involving the Nervous System: Presentation, Pathogenesis, and Management
- 3 January 2008
- journal article
- review article
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 34 (3) , 356-360
Abstract
Neuropsychiatric syndromes in systemic lupus erythematosus (SLE) have a wide range of severity and phenotype and are fairly common. Presentations are seen involving both central and peripheral nervous systems. Pathogenic mechanisms are thought to include vascular occlusion and hemorrhage, antineuronal antibodies, cytokine effects, choroid plexus dysfunction, neuroendocrine–immune effects, and direct central nervous system (CNS) tissue injury. Work-up includes serum, cerebrospinal fluid (CSF), and imaging studies. Treatment is based on severity and phenotype and includes steroids, anticoagulants, antidepressants, and cytotoxic approaches. Much remains to be done in terms of further elucidation of pathologic processes, correlation of these mechanisms with specific phenotypes, and management of the most severe presentations of neuropsychiatric lupus erythematosus.Keywords
This publication has 38 references indexed in Scilit:
- Complement activation in anti-phospholipid syndrome: A clue for an inflammatory process?Journal of Autoimmunity, 2007
- Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseasesAutoimmunity Reviews, 2007
- Influenza vaccination in systemic lupus erythematosus: Safe and protective?Autoimmunity Reviews, 2007
- B cell targeted therapy in autoimmunityJournal of Autoimmunity, 2007
- Antiphospholipid antibodies: Lessons from the benchJournal of Autoimmunity, 2007
- To smell autoimmunity: Anti-P-ribosomal autoantibodies, depression, and the olfactory systemJournal of Autoimmunity, 2007
- Human lupus autoantibodies against NMDA receptors mediate cognitive impairmentProceedings of the National Academy of Sciences, 2006
- Cognitive Impairment in Systemic Lupus Erythematosus and Neuropsychiatric Systemic Lupus Erythematosus: A Population-Based Neuropsychological StudyJournal of Clinical and Experimental Neuropsychology, 2003
- Expression of matrix metalloproteinase 9 (96‐kd gelatinase B) in human rheumatoid arthritisArthritis & Rheumatism, 1996
- Cognitive impairment in systemic lupus erythematosus: A neuropsychological study of individual and group deficitsJournal of Clinical and Experimental Neuropsychology, 1987